Approval · Notice of Compliance 877 · 2001
MALARONE: Notice of Compliance 877
Issued August 24, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 877
- Date
- August 24, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Antimalarial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MALARONE | 02238151 | Marketed |
Medicinal ingredients
- ATOVAQUONE 250 MG per TAB
- PROGUANIL HYDROCHLORIDE 100 MG per TAB